1 2 3 4 5

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; More

International Clinical Psychopharmacology . 32(3):147-154, May 2017.

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology . 32(5):281-288, September 2017.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major...

Higuchi, Teruhiko; Kamijima, Kunitoshi; Nakagome, Kazuyuki; More

International Clinical Psychopharmacology . 31(1):8-19, January 2016.

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

Kwon, Jun Soo; Kim, Sung Nyun; Han, Jaewook; More

International Clinical Psychopharmacology . 30(6):320-328, November 2015.

Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study

Clayton, Anita H.; Durgam, Suresh; Li, Dayong; More

International Clinical Psychopharmacology . 32(1):27-35, January 2017.

Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate

Montalvo, Itziar; Ortega, Laura; López, Xavi; More

International Clinical Psychopharmacology . 28(1):46-49, January 2013.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

Pae, Chi-Un; Wang, Sheng-Min; Han, Changsu; More

International Clinical Psychopharmacology . 32(5):235-248, September 2017.

Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders

Dell’Osso, Bernardo; Cremaschi, Laura; Palazzo, Carlotta; More

International Clinical Psychopharmacology . 30(1):29-35, January 2015.

Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study

Rolland, Benjamin; Valin, Thomas; Langlois, Carole; More

International Clinical Psychopharmacology . 30(1):49-53, January 2015.

Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology . 32(5):271-280, September 2017.

1 2 3 4 5